Nine Masts Capital’s Array Biopharma Inc ARRY Stock Holding History

Nine Masts Capital’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-85,900	Closed	-$3.98M	–	221
2019 Q2	$3.98M	Buy	+85,900	New	+$2.41M	0.57%	18

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return

Nine Masts Capital's ARRY Position: Q3 2019 in Review

Nine Masts Capital sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 85,900 shares — an estimated $3.98M sold.

Nine Masts Capital first reported a position in ARRY in Q2 2019 and held it in 1 quarter. The position peaked at $3.98M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Nine Masts Capital reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Nine Masts Capital sold 85,900 Array Biopharma Inc shares in Q3 2019, an estimated $3.98M.
Nine Masts Capital first reported a position in Array Biopharma Inc in Q2 2019 and held it in 1 quarter.
Nine Masts Capital's Array Biopharma Inc position peaked at $3.98M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Nine Masts Capital's 13F filing for Q3 2019, filed 12 Nov 2019.